14:00-14:20 |
¿¬±¸ÁÖÁ¦ÀÇ ¼±Á¤°ú ÇÁ·ÎÅäÄÝ ÀÛ¼º (Research question and protocol) |
ÇãÁ¤¿í |
¼º±Õ°üÀÇ´ë |
|
14:20-14:40 |
ÀÓ»ó½ÃÇè ¼³°èÀÇ ¿øÄ¢ (Principle of clinical trials design) |
¾È¼Ò¿¬ |
ºÐ´ç¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çù·Â¼¾ÅÍ |
|
14:40-15:00 |
¿¬±¸¿¡¼ °üÂûµÇ´Â ÈçÇÑ ¿À·ù (Error and confounder) |
Ȳ½Â½Ä |
¼¿ïÀÇ´ë º¸°Ç´ëÇпø º¸°ÇÇаú |
|
15:00-15:20 |
´Ùº¯·® ºÐ¼® (Multivariable analysis) |
Á¤¼öÁø |
°æÈñÀÇ°úÇבּ¸¿ø Åë°èÁö¿ø½Ç |
|
15:20-15:40 |
»ýÁ¸ºÐ¼® (Survival analysis) |
À±¹Ì¼÷ |
¾ç»êºÎ»ê´ëÇб³ ÀÇÇÐÅë°è½Ç |
|
14:00-14:10 |
Short-term outcomes of prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study) |
¾ç½ÂÀ± |
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ |
|
14:10-14:20 |
Are prognostic factors for recurrence a predictive marker for adjuvant chemotherapy in stage 2 colon caner? : Results from Korean multicenter large cohort study |
¹è¼º¿í |
°è¸íÀǴ뵿»êÀÇ·á¿ø |
|
14:20-14:30 |
Markedly Increased Risk of Colorectal Cancer and Decreased Risk of All Malignancies in Patients with Type 1 Narcolepsy: A Nationwide Population-Based Cohort Study |
Á¶ÀºÇý |
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ |
|
14:30-14:40 |
Enhanced long-term sustained endoscopic ink using self-healing phenylboronic acid polymer hydrogels produced by incorporation of carbon black |
·ùÁöÇö |
¿ø±¤´ëÇб³ ź¼ÒÀ¶ÇÕ°øÇаú |
|
14:40-14:50 |
Automatic Volumetric Segmentation Based on Deep Neural Network for Quantitative and Qualitative Assessment of Body Composition in Colorectal Cancer Patients |
Aiya Bimurzayeva |
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ |
|
14:50-15:00 |
Efficacy of geriatric multidisciplinary oncology clinic in surgical treatment decision process in elderly patients with colorectal cancer |
¼Á¤¿í |
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ºÐ´ç¼¿ï´ëÇб³º´¿ø |
|
15:00-15:10 |
Enhanced Recovery After Surgery (ERAS) in colorectal surgery: a survey study in Korea |
¹ÚÀ±¿µ |
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ |
|
15:10-15:20 |
An integrated magneto-electrochemical analysis of extracellular vesicle for the prediction of tumor response in patients with advanced colon cancer treated with preoperative FOLFOX chemotherapy. |
±èâÇö |
ȼøÀü³²´ëÇб³º´¿ø |
|
15:20-15:30 |
Long-term oncologic outcomes of cytotoreductive surgery with hyperthermic intraperitoneal chemotherapy to treat colorectal cancer with peritoneal carcinomatosis |
¹ÚÀºÁ¤ |
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ °³²¼¼ºê¶õ½ºº´¿ø |
|
15:30-15:40 |
Safety of early surgery after self-expandable metallic stenting for obstructed left-sided colorectal cancer |
¼Á¤¿í |
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ºÐ´ç¼¿ï´ëÇб³º´¿ø |
|
16:00-16:10 |
A new anti-mesenteric functional end-to-end stapled anastomosis: technical report with short-term postoperative complication |
ÀÌÇö±¸ |
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ |
|
16:10-16:20 |
Postoperative complications did not increase after early surgical intervention in patients with Crohn’s Disease who had received anti-TNF¥á |
±è¹üÁø |
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ |
|
16:20-16:30 |
Postoperative Outcome in Crohn’s Disease Patients Treated with Vedolizumab, Ustekinumab and Rizankizumab in Comparison with Those Treated with Anti-Tumor Necrosis Factor Agents |
Á¶ÀºÇý |
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ |
|
16:30-16:40 |
Surgical management of duodenal fistula in Crohn’s disease |
±è¿µÀÏ |
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ |
|
16:40-16:50 |
The recent increase of ulcerative colitis-associated colorectal cancer in surgical indication: 20 years’ experiences in a single tertiary center |
±èÈ¿ÁØ |
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ |
|
16:50-17:00 |
Short and long-term outcomes of surgical treatment in patients with intestinal Behcet’s disease |
¹Ú¹Î¿µ |
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ |
|
17:00-17:10 |
Clinical outcomes after short-term seton drainage was not worse than that of long-term seton drainage in patients with perianal Crohn’s disease: Preliminary study |
±è¼ÒÇö |
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ |
|
17:10-17:20 |
Natural history and long-term clinical course of anastomosis site involvement of Crohn's disease |
Á¤¼º¿ì |
Àϻ꺴¿ø |
|
17:20-17:30 |
Applying the modified Caprini score is an effective tool for preventing venous thromboembolism in colorectal cancer patients. |
Á¶ÇüÁø |
±¹±º ¾çÁÖº´¿ø |
|
17:30-17:40 |
Safety of stoma closure during postoperative chemotherapy in colorectal cancer |
ÀÌ°æÇÏ |
Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ |
|